1. Home
  2. RGNX vs CWBC Comparison

RGNX vs CWBC Comparison

Compare RGNX & CWBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • CWBC
  • Stock Information
  • Founded
  • RGNX 2008
  • CWBC 1989
  • Country
  • RGNX United States
  • CWBC United States
  • Employees
  • RGNX N/A
  • CWBC N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • CWBC Major Banks
  • Sector
  • RGNX Health Care
  • CWBC Finance
  • Exchange
  • RGNX Nasdaq
  • CWBC Nasdaq
  • Market Cap
  • RGNX 451.1M
  • CWBC 398.6M
  • IPO Year
  • RGNX 2015
  • CWBC 1996
  • Fundamental
  • Price
  • RGNX $9.26
  • CWBC $21.01
  • Analyst Decision
  • RGNX Strong Buy
  • CWBC Buy
  • Analyst Count
  • RGNX 8
  • CWBC 3
  • Target Price
  • RGNX $28.50
  • CWBC $21.67
  • AVG Volume (30 Days)
  • RGNX 528.4K
  • CWBC 38.6K
  • Earning Date
  • RGNX 11-05-2025
  • CWBC 10-23-2025
  • Dividend Yield
  • RGNX N/A
  • CWBC 2.27%
  • EPS Growth
  • RGNX N/A
  • CWBC 95.72
  • EPS
  • RGNX N/A
  • CWBC 1.39
  • Revenue
  • RGNX $155,782,000.00
  • CWBC $132,829,000.00
  • Revenue This Year
  • RGNX $203.27
  • CWBC $30.64
  • Revenue Next Year
  • RGNX $0.58
  • CWBC $6.58
  • P/E Ratio
  • RGNX N/A
  • CWBC $15.15
  • Revenue Growth
  • RGNX 74.95
  • CWBC 55.84
  • 52 Week Low
  • RGNX $5.04
  • CWBC $15.57
  • 52 Week High
  • RGNX $13.48
  • CWBC $22.89
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 52.58
  • CWBC 55.35
  • Support Level
  • RGNX $8.82
  • CWBC $20.90
  • Resistance Level
  • RGNX $10.08
  • CWBC $21.30
  • Average True Range (ATR)
  • RGNX 0.55
  • CWBC 0.30
  • MACD
  • RGNX -0.03
  • CWBC -0.05
  • Stochastic Oscillator
  • RGNX 42.66
  • CWBC 15.28

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About CWBC Community West Bancshares

Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the Company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments.

Share on Social Networks: